COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Home-Administered Trial of Direct Current Stimulation (HAT-DCS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02894736
Recruitment Status : Completed
First Posted : September 9, 2016
Last Update Posted : August 2, 2018
Information provided by (Responsible Party):
Colleen Loo, The University of New South Wales

Brief Summary:
Transcranial Direct Current Stimulation (tDCS) is a novel non-invasive brain stimulation treatment that is effective with no significant side effects. It can potentially be self-administered by patients in their own homes with remote monitoring, substantially reducing treatment costs and increasing accessibility, including to remote areas. This study will evaluate the feasibility and efficacy of home-administered tDCS treatment for depression.

Condition or disease Intervention/treatment Phase
Major Depression Device: Soterix tDCS machine Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Home-administered Transcranial Direct Current Stimulation (tDCS) Treatment for Depression
Study Start Date : March 2016
Actual Primary Completion Date : March 2018
Actual Study Completion Date : July 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Active tDCS
Soterix tDCS machine is used to administer active stimulation
Device: Soterix tDCS machine
Soterix tDCS machine - miniCT supervised neuromodulation system

Primary Outcome Measures :
  1. Montgomery Asberg Depression Rating Scale for Depression (MADRS) [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Subject meets criteria for a DSM-IV Major Depressive Episode, lasting more than 4 weeks
  • Total MADRS score ≥ 20

Exclusion Criteria:

  • Diagnosis of any DSM-IV psychotic disorder
  • History of drug or alcohol abuse or dependence in the preceding 3 months
  • High suicide risk
  • Clinically defined neurological disorder or insult
  • Metal in the cranium or skull defects
  • Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02894736

Layout table for location information
Australia, New South Wales
Black Dog Institute
Randwick, Sydney, New South Wales, Australia, 2031
Sponsors and Collaborators
The University of New South Wales
Layout table for investigator information
Principal Investigator: Angelo Alonzo, BSc(Hons)/BA, PhD University of New South Wales / Black Dog Institute
Layout table for additonal information
Responsible Party: Colleen Loo, Professor, The University of New South Wales Identifier: NCT02894736    
Other Study ID Numbers: HC15010
First Posted: September 9, 2016    Key Record Dates
Last Update Posted: August 2, 2018
Last Verified: August 2018
Additional relevant MeSH terms:
Layout table for MeSH terms
Behavioral Symptoms